GlassScriptPhysician profile
Britney Bertsch
NPI 1457553737
$883.08
in general payments reported to CMS, 2019-2025
20 companies · $230 in 2025
The $230 reported for 2025 was more than what 77% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $118 · 2020: $69.31 · 2021: $115 · 2022: $118 · 2023: $133 · 2024: $99.77 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $462.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $238.16 | 2020-2025 | Xifaxan |
| Glaxosmithkline, LLC. | $135.08 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $95.61 | 2025 | Jornay Pm |
| Vanda Pharmaceuticals INC. | $61.49 | 2024-2025 | Fanapt |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $47.61 | 2025 | Caplyta |
| Novo Nordisk INC | $45.05 | 2020-2022 | |
| Ironshore Pharmaceuticals INC. | $43.59 | 2023 | Jornay Pm |
| Amarin Pharma, INC. | $28.44 | 2021 | |
| Hologic Sales and Service, LLC | $26.35 | 2021 | |
| Abbott Laboratories | $21.21 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $18.60 | 2024 | Rexulti |
| Eisai INC. | $18.03 | 2022 | |
| Sobi, INC | $16.28 | 2019 | |
| Dexcom, INC. | $15.93 | 2021 | |
| Ironwood Pharmaceuticals, INC | $14.73 | 2023 | Linzess |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $14.43 | 2025 | Doc Band |
| Janssen Pharmaceuticals, INC | $13.59 | 2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $11.98 | 2021 | |
| Merck Sharp & Dohme LLC | $11.71 | 2019 | |
| Corium, LLC | $5.21 | 2024 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Britney Bertsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.